Kinnula V[au] - Search Results

Year	Number of Results
1975	1
1976	2
1977	1
1978	3
1979	1
1981	2
1984	1
1985	1
1988	1
1989	1
1990	3
1991	2
1992	6
1993	3
1994	5
1995	8
1996	6
1997	2
1998	9
1999	8
2000	11
2001	14
2002	13
2003	10
2004	17
2005	11
2006	18
2007	12
2008	18
2009	12
2010	17
2011	17
2012	18
2013	9
2014	2
2022	0

1

ELMOD2, a candidate gene for idiopathic pulmonary fibrosis, regulates antiviral responses.

Pulkkinen V, Bruce S, Rintahaka J, Hodgson U, Laitinen T, Alenius H, Kinnula VL, Myllärniemi M, Matikainen S, Kere J. Pulkkinen V, et al. Among authors: kinnula vl. FASEB J. 2010 Apr;24(4):1167-77. doi: 10.1096/fj.09-138545. Epub 2009 Dec 4. FASEB J. 2010. PMID: 19966137

2

Extracellular superoxide dismutase in pulmonary fibrosis.

Gao F, Kinnula VL, Myllärniemi M, Oury TD. Gao F, et al. Among authors: kinnula vl. Antioxid Redox Signal. 2008 Feb;10(2):343-54. doi: 10.1089/ars.2007.1908. Antioxid Redox Signal. 2008. PMID: 17999630 Free PMC article. Review.

3

Smoking and COPD-mechanisms and prevention.

Kinnula VL, Crapo JD. Kinnula VL, et al. COPD. 2009 Aug;6(4):231-3. doi: 10.1080/15412550903088841. COPD. 2009. PMID: 19811380 No abstract available.

4

Redox imbalance and lung fibrosis.

Kinnula VL. Kinnula VL. Antioxid Redox Signal. 2008 Feb;10(2):249-52. doi: 10.1089/ars.2007.1912. Antioxid Redox Signal. 2008. PMID: 17999634 No abstract available.

5

Extracellular superoxide dismutase and risk of COPD.

Oberley-Deegan RE, Regan EA, Kinnula VL, Crapo JD. Oberley-Deegan RE, et al. Among authors: kinnula vl. COPD. 2009 Aug;6(4):307-12. doi: 10.1080/15412550903085193. COPD. 2009. PMID: 19811392 Free PMC article. Review.

6

SIRT1 as a therapeutic target in inflammaging of the pulmonary disease.

Rahman I, Kinnula VL, Gorbunova V, Yao H. Rahman I, et al. Among authors: kinnula vl. Prev Med. 2012 May;54 Suppl(Suppl):S20-8. doi: 10.1016/j.ypmed.2011.11.014. Epub 2011 Dec 8. Prev Med. 2012. PMID: 22178470 Free PMC article. Review.

7

Strategies to decrease ongoing oxidant burden in chronic obstructive pulmonary disease.

Rahman I, Kinnula VL. Rahman I, et al. Among authors: kinnula vl. Expert Rev Clin Pharmacol. 2012 May;5(3):293-309. doi: 10.1586/ecp.12.16. Expert Rev Clin Pharmacol. 2012. PMID: 22697592 Free PMC article. Review.

8

Peroxiredoxins and their expression in ependymomas.

Haapasalo T, Nordfors K, Järvelä S, Kok E, Sallinen P, Kinnula VL, Haapasalo HK, Soini Y. Haapasalo T, et al. Among authors: kinnula vl. J Clin Pathol. 2013 Jan;66(1):12-7. doi: 10.1136/jclinpath-2012-201048. Epub 2012 Oct 16. J Clin Pathol. 2013. PMID: 23076395

9

Thiol proteins, redox modulation and parenchymal lung disease.

Kinnula VL, Vuorinen K, Ilumets H, Rytilä P, Myllärniemi M. Kinnula VL, et al. Curr Med Chem. 2007;14(2):213-22. doi: 10.2174/092986707779313345. Curr Med Chem. 2007. PMID: 17266580 Review.

10

Superoxide dismutases in malignant cells and human tumors.

Kinnula VL, Crapo JD. Kinnula VL, et al. Free Radic Biol Med. 2004 Mar 15;36(6):718-44. doi: 10.1016/j.freeradbiomed.2003.12.010. Free Radic Biol Med. 2004. PMID: 14990352 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results